A medical student who took a year out to work in research at the Wellcome Sanger Institute in Cambridge has gained a top prize in the prestigious Dr Falk-Pharma/Guts UK charity national awards. Mr Henry Lee-Six won the  award for his project entitled ‘Mutational Landscape of Normal Colon’ which examined potential causes of the evolution of colon cells from normal to cancerous.

Genomic surveillance has revealed that malaria resistance to two first-line antimalarial drugs has spread rapidly from Cambodia to neighbouring countries in Southeast Asia. Researchers discovered that descendants of one multi-drug resistant malaria strain are replacing the local parasites in Vietnam, Laos and northeastern Thailand, and are picking up additional new genetic changes which could further enhance resistance.

The 2019 report, Health, our global asset – partnering for progress features a postcard from Professor Nick Thomson, highlighting the importance of international collaboration in tracing cholera around the globe

Low doses of radiation equivalent to three CT scans, which are considered safe, give cancer-capable cells a competitive advantage over normal cells. Researchers studied the effects of low doses of radiation in mice and found it increases the number of cells with mutations in p53, a well-known genetic change associated with cancer. However, giving the mice an antioxidant before radiation promoted the growth of healthy cells, which outcompeted and replaced the p53 mutant cells.

Wellcome Sanger Institute researchers will receive funding from the Chan Zuckerberg Initiative (CZI) for five collaborative projects supporting the Human Cell Atlas (HCA), the global initiative to map every cell type in the human body. These projects will investigate specific tissues in the thymus, lung, liver, kidney and immune system to understand health and what goes wrong in disease.

In Nature Microbiology, scientists have identified which gene mutations make MRSA susceptible to a combination of penicillin and clavulanic acid. Analysing the whole-genome sequences of a diverse collection of MRSA strains revealed that a significant number of strains – including USA300 clone, the dominant strain in the United States – would be treatable with this drug combination.

For the first time, researchers have mapped the building blocks of the human lungs and airways, in both asthma patients and normal people. Understanding the cells and their signals could lead to finding new drug targets for treating asthma.

Professor Nicole Soranzo joins 48 fellow scientists from 17 countries in being elected as Members of the European Molecular Biology Organization (EMBO). An additional eight researchers from Argentina, Australia, Japan and the US have become Associate Members of the organisation whose mission is to promote excellence in European molecular life sciences research.

Researchers have mapped the most common bacterial cause of pneumonia around the world and revealed how these bacteria evolve in response to vaccination.

The research from the Wellcome Sanger Institute and collaborators offers incredible potential for studying human development and regenerative medicine. It is the first time scientists have been able to derive stem cells from early pig embryos and will also be beneficial for animal health and food production.